Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$4.69 - $9.84 $70,350 - $147,600
15,000 Added 15.79%
110,000 $857,000
Q4 2021

Jan 31, 2022

SELL
$14.7 - $19.89 $148,470 - $200,889
-10,100 Reduced 9.61%
95,000 $1.5 Million
Q3 2021

Oct 26, 2021

BUY
$11.99 - $17.9 $384,207 - $573,587
32,044 Added 43.86%
105,100 $1.88 Million
Q2 2021

Jul 30, 2021

BUY
$12.89 - $16.58 $812,791 - $1.05 Million
63,056 Added 630.56%
73,056 $1.14 Million
Q1 2021

May 03, 2021

SELL
$14.0 - $20.72 $166,600 - $246,568
-11,900 Reduced 54.34%
10,000 $144,000
Q4 2020

Feb 10, 2021

SELL
$12.67 - $26.23 $1.69 Million - $3.49 Million
-133,100 Reduced 85.87%
21,900 $430,000
Q3 2020

Oct 20, 2020

BUY
$11.92 - $15.87 $59,600 - $79,350
5,000 Added 3.33%
155,000 $2.01 Million
Q2 2020

Aug 12, 2020

BUY
$7.53 - $14.93 $301,200 - $597,200
40,000 Added 36.36%
150,000 $2.19 Million
Q1 2020

May 06, 2020

BUY
$5.69 - $17.78 $125,902 - $393,418
22,127 Added 25.18%
110,000 $936,000
Q4 2019

Feb 20, 2020

BUY
$10.89 - $16.79 $303,536 - $467,987
27,873 Added 46.46%
87,873 $1.45 Million
Q3 2019

Nov 01, 2019

BUY
$12.03 - $19.94 $421,050 - $697,900
35,000 Added 140.0%
60,000 $847,000
Q2 2019

Jul 31, 2019

BUY
$19.05 - $41.04 $476,250 - $1.03 Million
25,000 New
25,000 $503,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $728M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Trellus Management Company, LLC Portfolio

Follow Trellus Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellus Management Company, LLC with notifications on news.